Vivimed Labs Ltd will hold its sixth Committee of Creditors meeting on August 18, 2026, to discuss its insolvency resolution process. The company is currently managed by an Interim Resolution Professional under NCLT orders.
Vivimed Labs Ltd: Corporate Insolvency Resolution Process Update
Vivimed Labs Ltd's Committee of Creditors (CoC) will hold its sixth meeting on August 18, 2026, via audio-visual means. This follows an NCLT order on April 15, 2026, placing the company under Corporate Insolvency Resolution Process (CIRP).
Reader Takeaway: Company remains in insolvency proceedings; CoC meeting to guide future restructuring.
What just happened
Vivimed Labs Ltd has announced its 6th Committee of Creditors (CoC) meeting. It is scheduled for August 18, 2026, and will be conducted through audio-visual means.
Why this matters
This meeting is part of the ongoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code (IBC). The CoC's decisions are crucial for determining the company's future, including potential restructuring or liquidation. Investors should monitor these developments.
The backstory
Vivimed Labs Ltd is undergoing CIRP following an NCLT order dated April 15, 2026. The company's affairs are currently managed by an Interim Resolution Professional (IRP) as per the IBC.
History of CoC Meetings
The Committee of Creditors has held several meetings to date:
- First Meeting: May 13, 2026
- Second Meeting: May 29, 2026
- Third Meeting: June 18, 2026
- Fourth Meeting: July 4, 2026
- Adjourned Fourth Meeting: July 9, 2026
- Fifth Meeting: July 20, 2026
What changes now
The upcoming 6th CoC meeting will focus on the ongoing resolution process. Decisions made here will shape the company's path forward. No new financial guidance or operational updates are expected from the company during CIRP.